{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:45:19Z","timestamp":1787021119825,"version":"build-2736575974"},"reference-count":21,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>We reappraise the psychiatric potential of calcium channel blockers (CCBs). First, voltage-gated calcium channels are risk genes for several disorders. Second, use of CCBs is associated with altered psychiatric risks and outcomes. Third, research shows there is an opportunity for brain-selective CCBs, which are better suited to psychiatric indications.<\/jats:p>","DOI":"10.1192\/bjp.2019.157","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T04:46:06Z","timestamp":1561351566000},"page":"250-253","source":"Crossref","is-referenced-by-count":41,"title":["Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal"],"prefix":"10.1192","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-1126","authenticated-orcid":false,"given":"Paul J.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Tunbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette C.","family":"Dolphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"S0007125019001570_ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4411"},{"key":"S0007125019001570_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114553647"},{"key":"S0007125019001570_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12143"},{"key":"S0007125019001570_ref19","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08188"},{"key":"S0007125019001570_ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3311"},{"key":"S0007125019001570_ref21","first-page":"260562","article-title":"Long-read sequencing reveals the splicing profile of the calcium channel gene CACNA1C in human brain","author":"Clark","year":"2018","journal-title":"bioRxiv"},{"key":"S0007125019001570_ref1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198212233072605","article-title":"Mechanism of action of calcium-channel-blocking agents","volume":"307","author":"Braunwald","year":"1982","journal-title":"N Engl J Med"},{"key":"S0007125019001570_ref18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010818-021214"},{"key":"S0007125019001570_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2015.04.022"},{"key":"S0007125019001570_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.03.017"},{"key":"S0007125019001570_ref11","doi-asserted-by":"publisher","DOI":"10.1113\/JP270673"},{"key":"S0007125019001570_ref2","doi-asserted-by":"publisher","DOI":"10.1177\/070674379904400702"},{"key":"S0007125019001570_ref3","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.86"},{"key":"S0007125019001570_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.09.002"},{"key":"S0007125019001570_ref12","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.133"},{"key":"S0007125019001570_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby096"},{"key":"S0007125019001570_ref14","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.84"},{"key":"S0007125019001570_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3175-0"},{"key":"S0007125019001570_ref6","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009654"},{"key":"S0007125019001570_ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.3907"},{"key":"S0007125019001570_ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09494-2"}],"container-title":["The British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125019001570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T05:18:35Z","timestamp":1589260715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125019001570\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0007125019001570"],"URL":"https:\/\/doi.org\/10.1192\/bjp.2019.157","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]}}}